Atrial fibrillation and stroke:: clinical presentation of cardioembolic versus atherothrombotic infarction

被引:67
|
作者
Arboix, A
García-Eroles, L
Massons, JB
Oliveres, M
Pujades, R
Targa, C
机构
[1] Hosp del Sagrat Cor, Neurol Serv, Acute Stroke Unit, E-08025 Barcelona, Spain
[2] Hosp del Sagrat Cor, Intens Care Unit, Barcelona, Spain
[3] Hosp del Sagrat Cor, Serv Cardiol, Barcelona, Spain
关键词
atrial fibrillation; cerebral infarction; cardioembolic stroke; atherothrombotic stroke; cardiac dysrhythmia; valvular heart disease;
D O I
10.1016/S0167-5273(99)00214-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the study was to compare demographic characteristics, anamnestic findings, cerebrovascular risk factors, and clinical and neuroimaging data of cardioembolic stroke patients with and without atrial fibrillation and of atherothrombotic stroke patients with and without atrial fibrillation. Predictors of early diagnosis of cardioembolic vs. atherothrombotic stroke infarction in atrial fibrillation patients were also determined. Data of cardioembolic stroke patients with (n=266) and without (n=81) atrial fibrillation and of atherothrombotic stroke patients with (n=75) and without (n=377) were obtained from 2000 consecutive patients included in the prospective Sagrat Cor-Alianza Hospital of Barcelona Stroke Registry. Risk factors, clinical characteristics and neuroimaging features in these subgroups were compared. The independent predictive value of each variable on early diagnosis of stroke subtype was assessed with a logistic regression analysis. In-hospital mortality in patients with atrial fibrillation was significantly higher than in non-atrial fibrillation patients both in cardioembolic (32.6% vs. 14.8%, P<0.005) and atherothrombotic stroke (29.3% vs. 18.8%, P<0.04). Valvular heart disease (odds ratio (OR) 4.6; 95% confidence interval (95% CI) 1.19-17.68) and sudden onset (OR 1.8; 95% CI 0.97-3.63) were predictors of cardioembolic stroke, and subacute onset (OR 8; 95% CI 1.29-49.42), COPD (OR 5.2; 95% CI 1.91-14.21), hypertension (OR 3.63; 95% CI 1.92-6.85), hypercholesterolemia (OR 2.67; 95% CI 1.13-6.28), transient ischaemic attack (OR 2.49; 95% CI 1.05-5.90), ischaemic heart disease (OR 2.30; 95% CI 1.15-4.60) and diabetes (OR 2.26; 95% CI 1.14-4.47) of atherothrombotic stroke. In conclusion, some clinical features at stroke onset may help clinicians to differentiate cerebral infarction subtypes in patients with atrial fibrillation. Atrial fibrillation is associated with a higher in-hospital mortality both in cardioembolic and atherothrombotic stroke patients. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:33 / 42
页数:10
相关论文
共 50 条
  • [1] Effect of warfarin versus aspirin on blood viscosity in cardioembolic stroke with atrial fibrillation: a prospective clinical trial
    Chan-Hyuk Lee
    Keun-Hwa Jung
    Daniel J. Cho
    Seul-Ki Jeong
    BMC Neurology, 19
  • [2] Effect of warfarin versus aspirin on blood viscosity in cardioembolic stroke with atrial fibrillation: a prospective clinical trial
    Lee, Chan-Hyuk
    Jung, Keun-Hwa
    Cho, Daniel J.
    Jeong, Seul-Ki
    BMC NEUROLOGY, 2019, 19 (1)
  • [3] Cardioembolic acute myocardial infarction and stroke in a patient with persistent atrial fibrillation
    Kleczynski, Pawel
    Dziewierz, Artur
    Rakowski, Tomasz
    Rzeszutko, Lukasz
    Sorysz, Danuta
    Legutko, Jacek
    Dudek, Dariusz
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 161 (03) : E46 - E47
  • [4] Prevention of cardioembolic stroke in patients with atrial fibrillation
    Weber, Ralph
    Diener, Hans-Christoph
    Weimar, Christian
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2010, 8 (10) : 1405 - 1415
  • [5] Preventing Cardioembolic Stroke in Atrial Fibrillation with Dabigatran
    Weimar, Christian
    Hohnloser, Stefan H.
    Eikelboom, John W.
    Diener, Hans-Christoph
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2012, 12 (01) : 17 - 23
  • [6] Preventing Cardioembolic Stroke in Atrial Fibrillation with Dabigatran
    Christian Weimar
    Stefan H. Hohnloser
    John W. Eikelboom
    Hans-Christoph Diener
    Current Neurology and Neuroscience Reports, 2012, 12 : 17 - 23
  • [7] Clinical and Genetic Atrial Fibrillation Risk and Discrimination of Cardioembolic From Noncardioembolic Stroke
    Weng, Lu-Chen
    Khurshid, Shaan
    Gunn, Sophia
    Trinquart, Ludovic L.
    Lunetta, Kathryn
    Xu, Huichun J.
    NINDS Stroke Genetics Network, Patrick T.
    Benjamin, Emelia D.
    Ellinor, Patrick A.
    Anderson, Christopher
    Lubitz, Steven
    STROKE, 2023, 54 (07) : 1777 - 1785
  • [8] Acute renal infarction and cardioembolic stroke in a patient with atrial fibrillation and hyperthyroid-induced cardiomyopathy: A case report
    Adhikari S.
    Paudel K.
    Pandit K.
    Thapa S.
    Gajurel B.P.
    Dahal K.
    Journal of Medical Case Reports, 10 (1)
  • [9] Treatment strategies for prevention of cardioembolic stroke in atrial fibrillation
    Park, Jai-Wun
    Leithaeuser, Boris
    Rittger, Harald
    Brachmann, Johannes
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2010, 46 (04) : 251 - 264
  • [10] Cardioembolic stroke in atrial fibrillation and new anticoagulation criteria: a therapeutic dare
    Perez-Ortega, Irene
    Moniche-Alvarez, Francisco
    Dolores Jimenez-Hernandez, M.
    Gonzalez-Marcos, Jose R.
    REVISTA DE NEUROLOGIA, 2012, 55 (02) : 74 - 80